Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor ActivityJonathan D. Graves, Pamela M. Holland, Heather Douangpanya et al.|Cancer Cell|2014Cited by 155